Continuous Manufacturing of Recombinant Drugs: Comprehensive Analysis of Cost Reduction Strategies, Regulatory Pathways, and Global Implementation

Gardado en:

Detalles Bibliográficos
Publicado en:	Pharmaceuticals vol. 18, no. 8 (2025), p. 1157-1189
Autor Principal:	Niazi, Sarfaraz K
Publicado:	MDPI AG
Materias:	Food & Drug Administration > FDA United States > US Germany Monoclonal antibodies Product quality Collaboration Real time Batch processes Process controls Biological products Pharmaceutical industry Capital expenditures Batch processing Manufacturing Cost control 19th century Product testing
Acceso en liña:	Citation/Abstract Full Text + Graphics Full Text - PDF
Etiquetas:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Sexa o primeiro en deixar un comentario!